首页> 外国专利> COMPOSITIONS AND METHODS FOR COMBATING BACTERIAL INFECTIONS BY KILLING PERSISTER CELLS WITH MITOMYCIN C AND/OR CISPLATIN

COMPOSITIONS AND METHODS FOR COMBATING BACTERIAL INFECTIONS BY KILLING PERSISTER CELLS WITH MITOMYCIN C AND/OR CISPLATIN

机译:通过杀灭含丝裂霉素C和/或CISPLATIN的维持细胞来防治细菌感染的组合物和方法

摘要

The present disclosure provides a method for killing persister cells with mitomycin C and/or cisplatin, or derivatives thereof. Recalcitrant infections are difficult to treat due to persister cells, a subpopulation of all bacterial populations that is highly tolerant against all traditional antibiotics since the cells are dormant and antibiotics are designed to kill growing cells. Here, we show that MMC and cisplatin eradicate persister cells through a growth-independent mechanism, cross-linking DNA. We find both agents are effective against both planktonic cultures and highly robust biofilm cultures for a broad range of bacterial species, including commensal Escherichia coli K-12 as well as pathogenic species of E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa. In certain approaches cisplatin is superior to MMC.
机译:本公开提供了一种用丝裂霉素C和/或顺铂或其衍生物杀死持久性细胞的方法。顽固性感染由于持久性细胞而难以治疗,持久性细胞是所有细菌种群的亚群,由于细胞处于休眠状态,并且抗生素旨在杀死正在生长的细胞,因此对所有传统抗生素具有高度耐受性。在这里,我们显示MMC和顺铂通过与生长无关的机制(交联DNA)消除了持久性细胞。我们发现,这两种药物都对浮游细菌培养和高度健壮的生物膜培养物有效,适用于广泛的细菌物种,包括共生大肠杆菌 K-12和致病性物种 E。大肠杆菌,金黄色葡萄球菌铜绿假单胞菌。 在某些方法中,顺铂优于MMC。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号